TrumpRx deal: Congress must demand disclosure of the Trump trademark licensing arrangement.
POTUS may be violating the emoluments clause of the Constitution, and must provide full disclosure.
This article is a follow on to my previous post where I pointed out that renaming the previously planned as “Pfizer-for-All” pharmacy website into TrumpRx raises serious questions of trademark licensing revenue that Trump may be getting from Pfizer.
At the time of writing that article, I thought pointing out that Trump zealously licenses and enforces hi…
